| 8:00 - 8:15 |
Welcome and Overview
|
| 8:15 - 9:05 |
Andreas Rosenwald, MD - Universität Wüerzburg
Biology and Prognosis of High Grade Lymphomas
|
| 9:05 - 9:55 |
Sonali Smith, MD - The University of Chicago
Treatment options for relapsed DLCL
|
| 9:55 - 10:45 |
John Sweetenham, MD - Taussig Cancer Institute
Treatment of High Grade Lymphomas
|
| 10:45 - 11:05 |
Break
|
| 11:05 - 11:55 |
John Leonard, MD - Weill Medical College of Cornell University
New Monoclonal Antibodies in NHL
|
| 11:55 - 12:45 |
John Byrd, MD - The Ohio State University
CLL: Integration of Biology and Therapeutic Options
|
| 12:45 - 1:45 |
Andrew Evens, DO, MS - Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Lunch & Case Presentations
|
| 1:45 - 2:35 |
Julie Vose, MD - Nebraska Medical Center
Transformed Lymphoma: Definition, Prognosis, and Treatment
|
| 2:35 - 3:25 |
Keynote Address
Nancy Harris, MD - Harvard Medical School
Pathology and Classification of Follicular Lymphoma: WHO 2008
|
| 3:25 - 3:45 |
Break
|
| 3:45 - 4:35 |
Thomas Witzig, MD - Mayo Clinic
Sequencing of Therapies in Follicular Lymphoma
|
| 4:35 - 5:25 |
Jane Winter, MD - Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Vaccine Therapy in Lymphoma: Current State of the Art |
